Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
XPO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZDHHC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMURF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EEF1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WRNIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM200B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506922 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOH12CR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WBP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPA0 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TWISTNB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on